Details
June 6 @ 6:15 am – 7:45 am CDT
St James Ballroom, Hilton New Orleans Riverside
Supported By: Novo Nordisk
On-Demand
June 10 @ 12:00 pm – August 10 5:00 pm CDT
Program Description
The Novo Nordisk Corporate Symposium will be chaired by Dr Alice Cheng and will feature Dr Rodica Pop-Busui, Dr Marc Bonaca, Professor Peter Rossing and Dr Athena Philis-Tsimikas. The symposium will explore the evolving management of type 2 diabetes across the cardio-kidney-metabolic continuum, considering strategies to optimize glycemic control and weight control, as well as the broader impact on cardiovascular and kidney health. The expert panel will review the latest evidence for GLP-1–based therapies and emerging innovations, including once-weekly insulins, and share their perspectives on delivering coordinated, person-centered care across specialties. Through case-based discussion and the opportunity to ask questions, the audience will reflect on how to translate emerging evidence into clinical practice for people with T2D. We look forward to welcoming you to an engaging and informative symposium.
This meeting was organized and funded by Novo Nordisk, which manufactures and markets pharmaceutical products. The meeting contains scientific information provided for the purpose of scientific exchange. It may refer to data concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies.
This meeting is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product, or serve as basis for any decision or action.
Speakers
Moderator
Alice Cheng MD, FRCPC
Endocrinologist
Trillium Health Partners and St Michaels’ Hospital
Associate Professor
University of Toronto
Toronto, Canada
Presentation Title: Turning the Dial Up: Maximizing Glycemic and Weight Control with Advanced GLP‑1–Based Therapies
Presenter
Rodica Pop-Busui MD, PhD
Professor and Head of Division
Oregon Health and Science University
Portland, OR
Professor Emeritus
University of Michigan
Ann Arbor, MI
Presentation Title: Weekly insulin, daily outcomes: Bridging innovation and clinical practice
Presenter
Athena Philis-Tsimikas MD
Endocrinologist, Corporate Vice President,
Director of Community Engagement
Scripps Whittier Diabetes Institute
San Diego, CA
Presentation Title: Beyond glycemia and weight loss in T2D: Unlocking the glucose–weight–cardiometabolic cycle for better health
Presenter
Peter Rossing MD, DMSc
Professor and Head of Research, Clinical Translational Research
Steno Diabetes Center
Professor of Endocrinology
University of Copenhagen
Copenhagen, Denmark
Presentation Title: Beyond Glycemia and Weight Loss in T2D: Unlocking the Glucose–Weight–Cardiometabolic Cycle for Better Health
Presenter
Marc Bonaca MD, MPH
Cardiologist, Vascular Medicine Specialist, Executive Director
Colorado Prevention Center
Director of Vascular Research and Professor of Medicine
University of Colorado Anschutz
Aurora, CO